Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy

Journal:

Science Advances

Published:

2025-10-24

DOI:

10.1126/sciadv.adv6805

Affiliations:

8

Authors:

22

Go to article

Institutions	Authors	Share
Genethon, France	9.833333	0.45
Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE), France	5.333333	0.24
Institut Mondor de Recherche Biomédicale (IMRB), France	3.500000	0.16
AP-HP Pitié-Salpêtrière Hospital, France	2.000000	0.09
Saint Antoine Research Center (CRSA), France	0.500000	0.02
CHU Henri-Mondor, France	0.500000	0.02
Atamyo Therapeutics SAS, France	0.333333	0.02

Interested in Medical Biotechnology?